Subscribe to PRO at just Rs.33 per month. Use code SUPERPRO
you are here: HomeNewsIndia
Last Updated : Jun 29, 2020 04:10 PM IST | Source: Moneycontrol.com

Mylan's imports containing raw material for Remdesivir stuck at Mumbai Air Cargo: Report

The Maharashtra government on June 25 said it would procure anti-viral drugs Remdesivir and Favipiravir in large quantities for treatment of COVID-19 patients

Representative image
Representative image

Imports from pharmaceutical major Mylan, containing raw materials for Remdesivir and Favipiravir, have been stalled at Mumbai Air Cargo for five days, CNBC-TV18 reported.

Studies have found that anti-viral drugs Remdesivir and Favipiravir can aid in the treatment of novel coronavirus, or COVID-19.

The Maharashtra government on June 25 said it would procure anti-viral drugs Remdesivir and Favipiravir in large quantities for treatment of COVID-19 patients.


With over 1.6 lakh COVID-19 infections, Maharashtra is the most-affected state, and currently has over 70,000 active cases.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Gilead Science's Remdesivir has been found to speed the recovery time for COVID-19 patients. In India, Hetero Drugs and Cipla have received permission to manufacture and market remdesivir.
First Published on Jun 29, 2020 03:57 pm